Complement activation and hypersensitivity reactions to dialysis membranes. Hakim RM, Breillatt J, Lazarus JM, Port FK (1984) N Engl J Med 311: 878-82 Investigation of complement activation product c4d as a diagnostic and prognostic biomarker for lung cancer. Ajona D, Pajares MJ, Corrales L, Perez-Gracia JL, Agorreta J, Lozano MD, Torre W, Massion PP, de-Torres JP, Jantus-Lewintre E, Camps C, Zulueta JJ, Montuenga LM, Pio R (2013) J Natl Cancer Inst 105: 1385-93 Regulation of tumor necrosis factor receptor-1 and the IKK-NF-kappaB pathway by LDL receptor-related protein explains the antiinflammatory activity of this receptor. Gaultier A, Arandjelovic S, Niessen S, Overton CD, Linton MF, Fazio S, Campana WM, Cravatt BF, Gonias SL (2008) Blood 111: 5316-25 Intradialytic granulocyte reactive oxygen species production: a prospective, crossover trial. Himmelfarb J, Ault KA, Holbrook D, Leeber DA, Hakim RM (1993) J Am Soc Nephrol 4: 178-86 Complement activation retards resolution of acute ischemic renal failure in the rat. Schulman G, Fogo A, Gung A, Badr K, Hakim R (1991) Kidney Int 40: 1069-74 Effect of the membrane biocompatibility on nutritional parameters in chronic hemodialysis patients. Parker TF, Wingard RL, Husni L, Ikizler TA, Parker RA, Hakim RM (1996) Kidney Int 49: 551-6 Clinical implications of hemodialysis membrane biocompatibility. Hakim RM (1993) Kidney Int 44: 484-94 Modulation of granulocyte LAM-1 and MAC-1 during dialysis--a prospective, randomized controlled trial. Himmelfarb J, Zaoui P, Hakim R (1992) Kidney Int 41: 388-95 Biocompatibility of dialysis membranes: effects of chronic complement activation. Hakim RM, Fearon DT, Lazarus JM (1984) Kidney Int 26: 194-200 Localization of clusterin in the epimembranous deposits of passive Heymann nephritis. Eddy AA, Fritz IB (1991) Kidney Int 39: 247-52 Engineering complement activation on polypropylene sulfide vaccine nanoparticles. Thomas SN, van der Vlies AJ, O'Neil CP, Reddy ST, Yu SS, Giorgio TD, Swartz MA, Hubbell JA (2011) Biomaterials 32: 2194-203 Expression of complement regulatory proteins in accommodated xenografts induced by anti-alpha-Gal IgG1 in a rat-to-mouse model. Ding JW, Zhou T, Ma L, Yin D, Shen J, Ding CP, Tang IY, Byrne GW, Chong AS (2008) Am J Transplant 8: 32-40 Hyperacute rejection by anti-Gal IgG1, IgG2a, and IgG2b is dependent on complement and Fc-gamma receptors. Ding JW, Zhou T, Zeng H, Ma L, Verbeek JS, Yin D, Shen J, Chong AS (2008) J Immunol 180: 261-8 Histone Deacetylase 3 Is Required for T Cell Maturation. Hsu FC, Belmonte PJ, Constans MM, Chen MW, McWilliams DC, Hiebert SW, Shapiro VS (2015) J Immunol 195: 1578-90 Cutting Edge: NK cells mediate IgG1-dependent hyperacute rejection of xenografts. Yin D, Zeng H, Ma L, Shen J, Xu H, Byrne GW, Chong AS (2004) J Immunol 172: 7235-8 Defective platelet aggregation in uremia is transiently worsened by hemodialysis. Sreedhara R, Itagaki I, Lynn B, Hakim RM (1995) Am J Kidney Dis 25: 555-63 Hemodialysis-associated platelet activation and thrombocytopenia. Hakim RM, Schafer AI (1985) Am J Med 78: 575-80 Hyperacute lung rejection in the pig-to-human model. III. Platelet receptor inhibitors synergistically modulate complement activation and lung injury. Pfeiffer S, Zorn GL, Zhang JP, Giorgio TD, Robson SC, Azimzadeh AM, Pierson RN (2003) Transplantation 75: 953-9 Increased expression of the C3b receptor by neutrophils and complement activation during haemodialysis. Lee J, Hakim RM, Fearon DT (1984) Clin Exp Immunol 56: 205-14 Glomerular basement membrane heparan sulfate in health and disease: A regulator of local complement activation. Borza DB (2017) Matrix Biol 57-58: 299-310 Hemocompatibility of silicon-based substrates for biomedical implant applications. Muthusubramaniam L, Lowe R, Fissell WH, Li L, Marchant RE, Desai TA, Roy S (2011) Ann Biomed Eng 39: 1296-305 Clinical sequelae of complement activation in hemodialysis. Hakim RM (1986) Clin Nephrol 26 Suppl 1: S9-12
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.